Sofgen CDMO — a Sofgen Pharma company — is the global reference in softgel contract development and manufacturing. More than 50 years of expertise. Two world-class facilities in Colombia and Brazil. One clear purpose: to elevate every project we touch.
You have successfully submitted your enquiry. Someone from our company will respond ASAP
Sofgen CDMO — a Sofgen Pharma company — is the global reference in softgel contract development and manufacturing. Forged by more than 50 years of experience and driven by an unwavering commitment to quality, we support our partners across the entire product lifecycle — from development to delivery — specialising in generics, branded prescription drugs, OTC, and nutraceuticals for markets in North America, Canada, Europe, and beyond.
With two state-of-the-art facilities in Barranquilla, Colombia, and Cotia, Brazil — certified by the US FDA, TGA, Health Canada, and UK MHRA — we don’t just manufacture softgels. We elevate them.
Our comprehensive CDMO capabilities are designed to elevate every pharmaceutical project — from complex oral modalities and high-potency compounds to orphan drug development and advanced delivery systems:
Decades of mastery in softgel science have produced a portfolio of proprietary technologies available nowhere else. Our platform gives partners access to:
Our R&D teams are driven by science, guided by precision, and committed to unlocking the full potential of every molecule. Whether it’s a novel formulation or a complex NME, we bring the expertise to make it happen. Our R&D services include:
Advancing. Adapting. Aligned to the needs of an industry that never stops moving.
Sofgen CDMO. Never the same. Always elevated.
Health Canada certifies Sofgen CDMO® in Canadian Good Manufacturing Practices (GMP) for our compliance with the Food and Drug Regulations at its facilities. This new permit allows our production areas to manufacture, package, label, distribute, import, wholesale, and/or test a drug.
A technology trusted for over a century — and still the gold standard. Sofgen CDMO's softgel capsules deliver enhanced bioavailability, superior stability, and a dosage form that patients and consumers have relied on for generations.
One capsule. Multiple actives. Zero compromise. Unigel™ is Sofgen CDMO's first-to-market fixed-dose combination technology, engineered for organisations that demand simplicity, effectiveness, and innovation in a single form.
The softgel, reimagined for those who prefer to chew. Chewgels™ combines the proven benefits of softgel technology with custom shapes, flavours, and formulations, making compliance easier and line extensions smarter.
Precision in every twist. A soft gelatin capsule with a twist-off cap that delivers a measured dose for topical or oral applications, portable, tamper-evident, and designed for patients who need convenience without sacrificing accuracy.
Purpose-built for site-specific delivery. Vaogels' mucoadhesive design ensures active ingredient retention exactly where it's needed, with faster disintegration and superior treatment efficiency.
The familiar tablet, elevated. G-Tabs™ coats compressed tablets with a two-toned gelatin layer — combining the protection and appeal of a softgel with the formulation flexibility of a traditional tablet.
